Nosheen Nasir - Infectious Diseases

Author Information

Nosheen Nasir is a prominent researcher specializing in the field of Infectious Diseases. She is affiliated with the Section of Adult Infectious Diseases within the Department of Medicine at Aga Khan University, Karachi, Pakistan. Her work is focused on the clinical aspects and management of infectious diseases, particularly in the context of COVID-19 and related complications.

Research Contributions

Nosheen Nasir has made significant contributions to the understanding and management of infectious diseases, with a particular emphasis on COVID-19. Her research includes the study of COVID-19 associated mucormycosis, the clinical outcomes of immunomodulatory therapies, and the risk factors for bacterial infections in patients with COVID-19. Additionally, she has investigated the safety and efficacy of convalescent plasma treatment in COVID-19 patients and the long-term impact on lung function in individuals recovering from moderate to severe COVID-19. Her work is not only crucial in the current pandemic context but also extends to other infectious diseases such as tuberculosis in solid organ transplantation.

Aliases

Nosheen Nasir is also known by several aliases, including N Nasir and N. Nasir. These variations are often used in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citation Count	976
h-index	14
Total Paper Count	57

Publications:

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

DOI: 10.1016/S2666-5247(21)00237-8

Year: 2022

VITT with inactivated SARS-CoV-2 vaccine – index case

DOI: 10.1080/21645515.2022.2036556

Year: 2022

Clinical outcomes of immunomodulatory therapies in the management of COVID-19: A tertiary-care experience from Pakistan

DOI: 10.1371/journal.pone.0262608

Year: 2022

Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case control study

DOI: 10.1101/2021.01.09.21249498

Year: 2021

COVID-19 associated mucormycosis: a life-threatening complication in patients admitted with severe to critical COVID-19 from Pakistan

DOI: 10.1016/j.cmi.2021.07.038

Year: 2021

Clinical Features and Outcomes of Raoultella Terrigena Infections. A Single-center Experience from Karachi, Pakistan: A Retrospective Study

DOI: 10.21203/rs.3.rs-129254/v1

Year: 2021

Tuberculosis in Solid Organ Transplantation: Insights from TB Endemic Areas

DOI: 10.1007/s11908-021-00756-z

Year: 2021

Risk factors for bacterial infections in patients with moderate to severe COVID‐19: A case‐control study

DOI: 10.1002/jmv.27000

Year: 2021

Safety and Efficacy of Convalescent Plasma Treatment in COVID-19 Patients: Collate Trial

DOI: 10.35248/2157-7560.21.12.448

Year: 2021

Long Term Impact on Lung Function of Patients With Moderate and Severe COVID-19. A Prospective Cohort Study

DOI: 10.3389/fpubh.2021.663076

Year: 2021

What are Imaging Studies?

What Are Antimicrobial Stewardship Programs?

What are the Side Effects of Antimicrobials?

What are Isoprenoids?

What Diseases are Transmitted by Culex Mosquitoes?

How is Measles Diagnosed?

What are Sporozoites?

What Diseases are Transmitted by Aedes Albopictus?

How Does the Inflammatory Response Work?

What is Malaria?

Partnered Content Networks

Relevant Topics